L'OREAL financials
L'OREAL
529900JI1GG6F7RKVI53 | Line item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Income statement | |||
| Revenue | €44.05B | €43.49B | €41.18B |
| Cost of sales | €11.31B | €11.23B | €10.77B |
| Gross profit | €32.74B | €32.26B | €30.42B |
| Operating profit (EBIT) | €8.39B | €8.25B | €7.69B |
| Income tax expense | €2.36B | €2.02B | €1.81B |
| Profit for the year | €6.13B | €6.42B | €6.19B |
| — attributable to owners | €6.13B | €6.41B | €6.18B |
| — attributable to NCI | €6.5M | €7.8M | €6.5M |
| Total comprehensive income | €6.15B | €7.83B | €5.48B |
| Per share | |||
| Basic EPS | €11.48 | €11.99 | €11.55 |
| Diluted EPS | €11.44 | €11.95 | €11.52 |
| Cash flow statement | |||
| Net cash from operating activities | €8.66B | €8.29B | €7.60B |
| Net cash from investing activities | -€1.41B | -€3.70B | -€4.14B |
| Net cash from financing activities | -€1.40B | -€4.79B | -€1.61B |
| Dividends paid | €3.92B | €3.61B | €3.43B |
| Lease liability payments | €453.6M | €474.3M | €430.6M |
| Balance sheet | |||
| Total assets | €61.82B | €56.35B | €51.86B |
| Non-current assets | €39.62B | €39.88B | €35.53B |
| Property, plant & equipment | €4.21B | €4.20B | €3.87B |
| Right-of-use assets | €1.66B | €1.76B | €1.69B |
| Intangible assets & goodwill | €14.47B | €13.38B | €13.10B |
| Current assets | €22.20B | €16.47B | €16.33B |
| Inventories | €4.54B | €4.63B | €4.48B |
| Trade & other receivables | €5.50B | €5.60B | €5.09B |
| Cash & equivalents | €9.87B | €4.05B | €4.29B |
| Total equity | €35.00B | €33.14B | €29.08B |
| — attributable to owners | €34.95B | €33.13B | €29.07B |
| Non-controlling interests | €50.6M | €4.5M | €7.3M |
| Non-current liabilities | €11.45B | €8.58B | €7.87B |
| Long-term borrowings | €8.07B | €5.19B | €4.75B |
| Lease liabilities (non-current) | €1.36B | €1.46B | €1.39B |
| Current liabilities | €15.37B | €14.64B | €14.90B |
| Lease liabilities (current) | €434.5M | €468.6M | €459.8M |
| Deferred tax liabilities | €1.01B | €964.5M | €846.6M |
| Derived metrics | |||
| Operating margin | 19.0% | 19.0% | 18.7% |
| Net margin | 13.9% | 14.8% | 15.0% |
| Return on equity | 17.5% | 19.4% | 21.3% |
| Cash conversion ratio | 1.41× | 1.29× | 1.23× |
| Other reported items | |||
| Accumulated Other Comprehensive Income | €7.04B | €7.03B | €5.61B |
| Additional Paidin Capital | €3.51B | €3.44B | €3.37B |
| Adjustments For Deferred Tax Expense | €68.2M | -€37.4M | -€95.3M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €37.8M | €15.2M | €6.9M |
| Adjustments For Sharebased Payments | €248.3M | €239.1M | €168.5M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€6.7M | -€2.9M | €200.0K |
| Advertising Expense | €14.18B | €14.01B | €13.36B |
| Cancellation of Treasury Shares | €0 | €0 | -€200.0K |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -€609.7M | -€1.78B | -€823.7M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €8.33B | €8.51B | €8.00B |
| Cash Outflow For Leases | €581.2M | €611.7M | €539.2M |
| Comprehensive Income Attributable To Noncontrolling Interests | €5.4M | €7.5M | €5.9M |
| Comprehensive Income Attributable To Owners of Parent | €6.14B | €7.82B | €5.48B |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €2.05B | €1.38B | €2.09B |
| Current Provisions | €1.12B | €1.09B | €977.2M |
| Current Tax Assets Current | €226.0M | €234.1M | €191.6M |
| Current Tax Liabilities Current | €254.8M | €275.1M | €208.1M |
| Current Tax Liabilities Noncurrent | €236.6M | €224.3M | €255.7M |
| Deferred Tax Assets | €962.7M | €973.3M | €921.2M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €3.88B | — | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €7.20 | — | — |
| Dividends Received Classified As Operating Activities | €351.9M | €447.6M | €423.6M |
| Dividends Recognised As Distributions To Owners Per Share | €7.00 | — | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€39.2M | -€32.8M | -€175.9M |
| Equity and Liabilities | €61.82B | €56.35B | €51.86B |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €12.4M | -€4.1M | -€22.7M |
| Income Tax Relating To Components of Other Comprehensive Income | €71.1M | €68.3M | -€51.6M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €12.4M | -€4.1M | -€22.7M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €58.6M | €72.5M | -€28.9M |
| Income Tax Relating To Financial Assets Measured At Fair Value Through Other Comprehensive Income | €29.3M | €33.3M | €1.3M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €29.3M | €39.2M | -€30.2M |
| Income Taxes Paid Refund | €2.39B | €2.02B | €2.00B |
| Increase Decrease In Cash and Cash Equivalents | €5.81B | -€235.8M | €1.67B |
| Increase Decrease In Number of Ordinary Shares Issued | 0.8M | 0.9M | 0.8M |
| Increase Decrease In Working Capital | -€327.4M | €226.6M | €394.9M |
| Increase Decrease Through Sharebased Payment Transactions | €248.3M | €239.1M | €168.5M |
| Increase Decrease Through Transfers and Other Changes Equity | -€357.8M | -€13.8M | -€600.0K |
| Increase Decrease Through Treasury Share Transactions | -€501.5M | -€497.5M | -€503.3M |
| Intangible Assets Other Than Goodwill | €5.07B | €4.59B | €4.29B |
| Interest Income On Cash and Cash Equivalents | €167.7M | €148.7M | €162.1M |
| Interest Paid Classified As Operating Activities | €299.9M | €323.1M | €184.9M |
| Investment Accounted For Using Equity Method | €376.0M | €126.4M | €27.0M |
| Issue of Equity | €65.5M | €69.9M | €1.7M |
| Issued Capital | €106.8M | €106.9M | €106.9M |
| Noncurrent Financial Assets | €12.87B | €14.84B | €11.63B |
| Noncurrent Provisions For Employee Benefits | €684.0M | €668.9M | €562.0M |
| Number of Shares Outstanding | 533.8M | 534.3M | 534.7M |
| Other Adjustments For Noncash Items | €17.4M | €21.1M | €14.1M |
| Other Comprehensive Income | €13.3M | €1.41B | -€707.0M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | €116.9M | -€77.1M | -€137.3M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -€985.3M | €260.6M | -€425.8M |
| Other Comprehensive Income Before Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | €848.4M | €1.14B | -€76.3M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €104.4M | €154.2M | -€119.3M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €104.4M | -€72.9M | -€114.5M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€985.3M | €260.6M | -€425.8M |
| Other Comprehensive Income Net of Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | €819.1M | €1.11B | -€77.5M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €75.1M | €115.0M | -€89.2M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€880.9M | €187.7M | -€540.3M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €894.2M | €1.23B | -€166.7M |
| Other Finance Income Cost | -€38.0M | -€39.8M | -€51.5M |
| Other Longterm Provisions | €84.5M | €76.8M | €68.8M |
| Payments From Changes In Ownership Interests In Subsidiaries | €16.3M | €13.9M | €0 |
| Proceeds From Issuing Shares | €65.6M | €69.9M | €1.5M |
| Proceeds From Noncurrent Borrowings | €4.06B | €1.53B | €3.57B |
| Repayments of Noncurrent Borrowings | €22.6M | €7.9M | €0 |
| Research and Development Expense | €1.38B | €1.35B | €1.29B |
| Retained Earnings Excluding Profit Loss For Reporting Period | €18.17B | €16.14B | €13.80B |
| Retained Earnings Profit Loss For Reporting Period | €6.13B | €6.41B | €6.18B |
| Revenue From Dividends | €351.9M | €447.6M | €423.6M |
| Selling General and Administrative Expense | €8.29B | €8.21B | €7.63B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€5.5M | -€1.3M | €200.0K |
| Trade and Other Current Payables To Trade Suppliers | €6.73B | €6.47B | €6.35B |
Every line item above is a fact tagged in L'OREAL's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.